In continuation to the post on Febraury 10, 2009, Mar 23, 2009 - Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) confirmed today that it has filed a patent infringement lawsuit against Teva Parenteral Medicines, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. The complaint, which was filed in the U.S. District Court for the District of Delaware, alleges infringement of US Patent Nos. 6,468,967 and 6,852,689, which expire on September 24, 2019, and US Patent No. RE39,071, which expires on June 15, 2016.
the details can be read here.
No comments:
Post a Comment